|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0021270,
umls-concept:C0023981,
umls-concept:C0027819,
umls-concept:C0087111,
umls-concept:C0392756,
umls-concept:C0812287,
umls-concept:C1274040,
umls-concept:C1518409,
umls-concept:C1519810,
umls-concept:C1521871,
umls-concept:C1551022,
umls-concept:C1961136
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-1-31
|
|
pubmed:abstractText |
To evaluate the efficacy of low-dose chemotherapy in infants with nonmetastatic and unresectable neuroblastoma (NB) without MYCN amplification.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:AmbrosPeterP,
pubmed-author:BoniLucaL,
pubmed-author:BrichardBénédicteB,
pubmed-author:BrockPenelopeP,
pubmed-author:CaneteAdelaA,
pubmed-author:CastelVictoriaV,
pubmed-author:CouturierJérômeJ,
pubmed-author:De BernardiBrunoB,
pubmed-author:Di CataldoAndreaA,
pubmed-author:GaraventaAlbertoA,
pubmed-author:GerrardMaryM,
pubmed-author:HolmesKeithK,
pubmed-author:LadensteinRuthR,
pubmed-author:MarquezCatalinaC,
pubmed-author:MichonJeanJ,
pubmed-author:MosseriVéroniqueV,
pubmed-author:MunzerCarolineC,
pubmed-author:PearsonAndrew D JAD,
pubmed-author:PlantazDominiqueD,
pubmed-author:RubieHervéH,
pubmed-author:Valteau-CouanetDominiqueD
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
449-55
|
|
pubmed:meshHeading |
pubmed-meshheading:21172879-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:21172879-Disease-Free Survival,
pubmed-meshheading:21172879-Europe,
pubmed-meshheading:21172879-Female,
pubmed-meshheading:21172879-Gene Amplification,
pubmed-meshheading:21172879-Humans,
pubmed-meshheading:21172879-Infant,
pubmed-meshheading:21172879-Infant, Newborn,
pubmed-meshheading:21172879-Kaplan-Meier Estimate,
pubmed-meshheading:21172879-Male,
pubmed-meshheading:21172879-Neoplasm Recurrence, Local,
pubmed-meshheading:21172879-Neoplasm Staging,
pubmed-meshheading:21172879-Neuroblastoma,
pubmed-meshheading:21172879-Nuclear Proteins,
pubmed-meshheading:21172879-Oncogene Proteins,
pubmed-meshheading:21172879-Prospective Studies,
pubmed-meshheading:21172879-Risk Assessment,
pubmed-meshheading:21172879-Risk Factors,
pubmed-meshheading:21172879-Survival Rate,
pubmed-meshheading:21172879-Time Factors,
pubmed-meshheading:21172879-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1.
|
|
pubmed:affiliation |
Unité d'Hémato-Oncologie, Hôpital des Enfants, Toulouse, France. rubie.h@chu-toulouse.fr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study
|
